Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model

por Kalra, Jessica, Baker, Jennifer, Song, Justin, Kyle, Alastair, Minchinton, Andrew, Bally, Marcel
Publicado 2021

Dosimetry with a clinical linac adapted to FLASH electron beams

por Szpala, Stanislaw, Huang, Vicky, Zhao, Yingli, Kyle, Alastair, Minchinton, Andrew, Karan, Tania, Kohli, Kirpal
Publicado 2021

DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost

por Wang, Taixiang, Kyle, Alastair H., Baker, Jennifer H. E., Liu, Nannan A., Banáth, Judit P., Minchinton, Andrew I.
Publicado 2023

Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin

por Baker, Jennifer H. E., Kyle, Alastair H., Bartels, Kirsten L., Methot, Stephen P., Flanagan, Erin J., Balbirnie, Andrew, Cran, Jordan D., Minchinton, Andrew I.
Publicado 2013

Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment

por Baker, Jennifer Hazel Elizabeth, Kyle, Alastair Hugh, Reinsberg, Stefan Alexander, Moosvi, Firas, Patrick, Haley Margaret, Cran, Jordan, Saatchi, Katayoun, Häfeli, Urs, Minchinton, Andrew Ivor
Publicado 2018

The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular functi...

por Yapp, Donald T., Wong, May Q., Kyle, Alastair H., Valdez, Shannon M., Tso, Jenny, Yung, Andrew, Kozlowski, Piotr, Owen, David A., Buczkowski, Andrzej K., Chung, Stephen W., Scudamore, Charles H., Minchinton, Andrew I., Ng, Sylvia S. W.
Publicado 2016